Causes and frequency of blindness in patients with intraocular inflammatory disease.

Nussenblatt RB. The natural history of uveitis. Int Ophthalmol 1990; 14: 303-8.

Forrester JV. Uveitis: pathogenesis. Lancet 1991; 338: 1498-501.

Vadot E, Barth E, Billet P. Epidemiology of uveitis - preliminary results of a prospective study in Savoy. In: Saari KM, ed. Uveitis update. Amsterdam: Elsevier, 1984: 13-6.

Ronday MJH, Stilma JS, Barbe RF, Kijlstra A, Rothova A. Blindness from uveitis in a hospital population in Sierra Leone. BrJ Ophthalmol 1994; 78: 690-3.

Doesschate ten J. Causes of blindness in the Netherlands. Doc Ophthalmol 1982; 52: 279-85.

Research to Prevent Blindness. Annual report 1993.

Madison Avenue, New York, 1993: 4.

Bloch-Michel E, Nussenblatt RB. International uveitis study group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 1987; 103: 234-6.

Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology 1994; 101: 389-96.

Rothova A, Buitenhuis HJ, Meenken C, Brinkman CJJ, Linssen A, Alberts C, et al. Uveitis and systemic disease. BrJ7 Ophthalmol 1992; 76: 137-41.

Bennet PH, Burch TA. New York symposium on population studies in the rheumatic diseases. New diagnostic criteria. Bull Rheum Dis 1967; 17: 453-8.

Kraut JA, McCabe CP. The problem of low vision. Definition and common problems. In: Albert DM, Jakobiec FA, eds. Principles and practice of ophthalmology. Philadelphia: W B Saunders, 1994; 5: 3664-6.

McGavin M. Reaching for high standards of eye care. Community Eye Health 1993; 6: 1-2.

Lightman S. Uveitis: management. Lancet 1991; 338: 1501-4.

Barton K, Hall AJH, Rosen PH, Cooling RJ, Lightman S. Systemic steroid prophylaxis for cataract surgery in patients with posterior uveitis. Ocular Immunology and Inflammation 1994; 2: 207-16.

Rothova A, Alberts C, Glasius E, Kijlstra A, Buitenhuis HJ, Breebaart AC. Risk factors for ocular sarcoidosis. Doc Ophthalmol 1989; 72: 287-96.

Foster CS. Ocular manifestations of sarcoidosis preceding systemic manifestations. In: Grassi C, Rizatto G, Pozzi E, eds. Sarcoidosis and other granulomatous disorders. Amsterdam: Exerpta Medica, 1988: 177-81.

Loewer-Sieger DH, Rothova A, Koppe JG, Kijlstra A. Congenital toxoplasmosis: a prospective study based on 1821 pregnant women. In: Saari KM, ed. Uveitis update. Amsterdam: Elsevier, 1984: 203-7.

Wilson CB, Remington JS, Stagno S, Reynold DW. Development ofadverse sequelae in children born with subclinical toxoplasma infection. Pediatrics 1980; 66: 767-74.

McAuleyJ, Boyer KM, Patel D, Mets M, Swisher C, Roizen N, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago collaborative treatment trial. Clin Infect Dis 1994; 18: 38-72.

McCabe R, Remington JS. Toxoplasmosis: the time has come. NEnglJMed 1988; 318: 313-5.

Foulon W, Naessens A, Derde MP. Evaluation of the possibilities for preventing congenital toxoplasmosis. Am jPermnatol 1994; 11: 57-62.

Rothova A, Veenendaal WG van, Linssen A, Glasius E, Kijlstra A, Jong PTVM de. Clinical features of acute anterior uveitis. AmJ Ophthalmol 1987; 103: 137-45.

Rodriguez A, Akova YA, Pedroza-Seres M, Foster CS. Posterior segment ocular manifestations in patients with HLA-B27 associated uveitis. Ophthalmology 1994; 101: 1267-74.

Boer de JH, Luyendijk L, Rothova A, Baarsma GS, Jong de PTVM, Bollemeijer JG, et al. Detection of intraocular antibody production to herpesviruses in acute retinal necrosis syndrome. Am Jf Ophthalmol 1994; 117: 201-10.

Wolf MD, Lichter PR, Ragsdale CG. Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology 1987; 94: 1242-8.

Weiss H, Annesley WH Jr, Shields JA, Tomer T, Christopherson K. The clinical course of serpiginous choroidopathy. Am J Ophthalmol 1979; 87: 133-42.

Laatikainen L, Erkkila H. A follow-up study on serpiginous choroiditis. Acta Ophthalmol (Copenh) 1981; 59: 707-18.

Nussenblatt RB, Palestine AG. Birdshot retinochoroidopathy. In: Uveitis. Fundamentals and clinical practice. Chicago: Year Book Medical Publishers, 1989: 248-56.

Ryan SJ, Maumenee AE. Birdshot retinochoroidopathy. Am J Ophthalmol 1980; 89: 31-45.

Priem HA, Oosterhuis JA. Birdshot chorioretinopathy: clinical characteristics and evolution. Br Jf Ophthalmol 1988; 72: 646-59.

Mamo JG. The rate of visual loss in Behcet's disease. Arch Ophthalmol 1970; 84: 451-2.

Cochereau-Massin I, Wechsler B, Le Hoang P, Le Thi Huong Du, Girard B, Rousselie F, et al. Prognostic oculaire de la maladie de Behcet. J Fr Ophtalmol 1992; 15: 343-47.

Towler HMA, Lightman S. Visual prognosis is Behcet's disease. Ocular Immunology and Inflammation 1993; 1: 249-54.

Hikichi T, Trempe CL. Role of the vitreous in the prog-nosis of peripheral uveitis. Am J Ophthalmol 1993; 116: 401-5.

Malinowski SM, Folk JC, Pulido JS. Pars planitis. Curr Opin Ophthalmol 1994; 5: 72-82.

Pruett RC, Brockhurst RJ, Letts NF. Fluorescein angiography of peripheral uveitis. Am J Ophthalmol 1974; 77: 448-53.

Chester GH, Blach RK, Cleary PE. Inflammation in the region of the vitreous base. Pars planitis. Trans Ophthalmol Soc UK 1976; 96: 151-7.

Dick AD. The treatment of chronic uveitic macular oedema. Is immunosuppression enough? BrJ Ophthalmol 1994; 78: 1-2.

Heiligenhaus A, Bornfeld N, Foerster MH, Wessing A. Long term results of pars plana vitrectomy in the management of complicated uveitis. Br J Ophthalmol 1994; 78: 549-54.